0001145549-22-022256.txt : 20220418 0001145549-22-022256.hdr.sgml : 20220418 20220418120503 ACCESSION NUMBER: 0001145549-22-022256 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220131 FILED AS OF DATE: 20220418 DATE AS OF CHANGE: 20220418 EFFECTIVENESS DATE: 20220418 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Virtus AllianzGI Equity & Convertible Income Fund CENTRAL INDEX KEY: 0001383441 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-21989 FILM NUMBER: 22831487 BUSINESS ADDRESS: STREET 1: 101 MUNSON STREET CITY: GREENFIELD STATE: MA ZIP: 01301 BUSINESS PHONE: (866) 270-7598 MAIL ADDRESS: STREET 1: 101 MUNSON STREET CITY: GREENFIELD STATE: MA ZIP: 01301 FORMER COMPANY: FORMER CONFORMED NAME: AllianzGI Equity & Convertible Income Fund DATE OF NAME CHANGE: 20130502 FORMER COMPANY: FORMER CONFORMED NAME: AGIC Equity & Convertible Income Fund DATE OF NAME CHANGE: 20100825 FORMER COMPANY: FORMER CONFORMED NAME: Nicholas-Applegate Equity & Convertible Income Fund DATE OF NAME CHANGE: 20070118 N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0001383441 XXXXXXXX false false false N-2 Virtus AllianzGI Equity & Convertible Income Fund 811-21989 0001383441 549300E7CGC36IOELF91 101 MUNSON STREET GREENFIELD 01301-9668 US-MA US 800-254-5197 The Bank of New York Mellon 240 Greenwich Street New York 10286 1-212-495-1784 Records related to its functions as custodian. Ropes & Gray LLP Prudential Tower 800 Boylston Street Boston 02199-3600 617-951-7000 Records related to its functions as Legal Counsel Virtus Investment Advisers, Inc. One Financial Plaza Hartford 06103 800-248-7971 Records related to its functions as Investment Adviser Virtus Fund Services, LLC One Financial Plaza Hartford 06103 800-243-1574 Records related to its functions as Administrator American Stock Transfer & Trust Company, LLC 6201 15th Avenue Brooklyn 11219 800-937-5449 Records related to its functions as transfer agent and shareholder service agent Allianz Global Investors U.S. LLC 1633 Broadway 41st Floor New York 10019 212-739-3000 Records related to its functions as subadviser N N N-2 Y Brian T. Zino N/A N William B. Ogden, IV N/A N Philip R. McLoughlin N/A N George R. Aylward N/A Y Deborah A. DeCotis N/A N Sarah E. Cogan N/A N F. Ford Drummond N/A N James S. MacLeod N/A N Alan Rappaport 001029265 N Nancy J. Engberg 002952960 One Financial Plaza 26th Floor Hartford 06103 XXXXXX N N N N N N PricewaterhouseCoopers LLP 238 5493002GVO7EO8RNNS37 N N N 2021-02-01 Change from mean to last trade if available otherwise mean Other Options Options Purchased N/A 2021-02-01 Change from use of mean price to bid price Other Fixed income securities Fixed Income Securities N/A 2021-02-01 Change in the trigger threshold for use of fair value factors Other International equities Common Stocks N/A N N Virtus AllianzGI Equity & Convertible Income Fund 549300E7CGC36IOELF91 N 0 0 0 N/A N N Y N N/A N/A N/A Rule 12d1-1 (17 CFR 270.12d1-1) Rule 32a-4 (17 CFR 270.32a-4) Rule 12d1-4 (17 CFR 270.12d1-4) Y Y Y N Virtus Investment Advisers, Inc. 801-5995 000106982 5493008GM1PP47SEXR11 N Allianz Global Investors U.S. LLC 801-69803 000149003 549300QJHGSKBIX1VE40 N N American Stock Transfer & Trust Company, LLC 084-00416 254900TS5EWP83BEOU02 N N N Bloomberg L.P. 549300B56MD0ZC402L06 N Refinitiv US Holdings Inc. 549300NF240HXJO7N016 N IHS Markit Ltd. 549300HLPTRASHS0E726 GB N ICE Data Services, Inc. 13-3668779 N N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) The Depository Trust Company 549300HBJLRO8YFMI370 N Y Securities depository - rule 17f-4 (17 CFR 270.17f-4) Y American Stock Transfer & Trust Company, LLC 254900TS5EWP83BEOU02 N N N Virtus Fund Services, LLC 084-06485 SEC file number Y N N VP Distributors, LLC 008-14100 000003036 549300IW1QX018U5W603 0.000000000000 PIMCO Canada Corp. N/A N/A 549300PNZNS0LQSMZ318 CA 0.000000000000 PIMCO Europe GmbH N/A N/A 549300KW6332H0XL8X85 DE 0.000000000000 PIMCO Investments LLC 008-68686 000154957 N/A 0.000000000000 Allianz Global Investors (Schweiz) AG N/A N/A 549300HHHNE56IHKY326 CH 0.000000000000 Allianz Global Investors Distributors LLC 008-41811 000025567 549300SP22LYR965RW31 0.000000000000 Allianz Life Financial Services, LLC 008-13630 000000612 5493008TSI0TRWDDGW79 0.000000000000 OPPENHEIMER & CO. INC. 008-04077 000000249 254900VH02JQR2L8XD64 19884.020000000000 BOFA SECURITIES, INC. 008-69787 000283942 549300HN4UKV1E2R3U73 23777.730000000000 CREDIT SUISSE SECURITIES (USA) LLC 008-00422 000000816 1V8Y6QCX6YMJ2OELII46 33606.180000000000 JEFFERIES LLC 008-15074 000002347 58PU97L1C0WSRCWADL48 11661.020000000000 MORGAN STANLEY & CO. LLC 008-15869 000008209 9R7GPTSO7KV3UQJZQ078 53543.280000000000 Stephens, Inc. 008-01927 000003496 213800LH6T9XDYZCA534 4576.820000000000 KEYBANC CAPITAL MARKETS, INC. 008-30177 000000566 2EQWV0180Z211YVAD813 6888.100000000000 GOLDMAN SACHS & CO. LLC 008-00129 000000361 FOR8UP27PHTHYVLBNG30 21485.460000000000 J.P. Morgan Securities LLC 008-35008 000000079 ZBUT11V806EZRVTWT807 8129.120000000000 BARCLAYS CAPITAL, INC. 008-41342 000019714 AC28XWWI3WIBK2824319 6119.860000000000 227458.000000000000 J.P. Morgan Securities LLC 008-35008 000000079 ZBUT11V806EZRVTWT807 47720201.840000000000 WELLS FARGO SECURITIES, LLC 008-65876 000126292 VYVVCKR63DVZZN70PB21 56453404.110000000000 BOFA SECURITIES, INC. 008-69787 000283942 549300HN4UKV1E2R3U73 55236050.100000000000 NOMURA SECURITIES INTERNATIONAL, INC. 008-15255 000004297 OXTKY6Q8X53C9ILVV871 23720078.740000000000 MORGAN STANLEY & CO. LLC 008-15869 000008209 9R7GPTSO7KV3UQJZQ078 47924854.960000000000 JEFFERIES LLC 008-15074 000002347 58PU97L1C0WSRCWADL48 23334335.780000000000 GOLDMAN SACHS & CO. LLC 008-00129 000000361 FOR8UP27PHTHYVLBNG30 57238888.210000000000 CREDIT SUISSE SECURITIES (USA) LLC 008-00422 000000816 1V8Y6QCX6YMJ2OELII46 16275745.420000000000 CitiGroup Global Markets Inc. 008-08177 000007059 MBNUM2BPBDO7JBLYG310 15672598.580000000000 BARCLAYS CAPITAL, INC. 008-41342 000019714 AC28XWWI3WIBK2824319 69921487.350000000000 399787513.000000000000 Y 903704441.020000000000 0.000000000000 Common stock AllianzGI Equity & Convertible Income Fund N N N N N N 1.000000000000 1.120000000000 27.330000000000 30.320000000000 true INTERNAL CONTROL RPT 2 v131.htm

 

Report of Independent Registered Public Accounting Firm 

To the Board of Trustees of Virtus AllianzGI Artificial Intelligence & Technology Opportunities Fund, Virtus AllianzGI Convertible & Income 2024 Target Term Fund, Virtus AllianzGI Convertible & Income Fund, Virtus AllianzGI Convertible & Income Fund II, Virtus AllianzGI Diversified Income & Convertible Fund, Virtus AllianzGI Equity & Convertible Income Fund, and Virtus Dividend, Interest & Premium Strategy Fund 

In planning and performing our audits of the financial statements of Virtus AllianzGI Artificial Intelligence & Technology Opportunities Fund, Virtus AllianzGI Convertible & Income 2024 Target Term Fund, Virtus AllianzGI Convertible & Income Fund, Virtus AllianzGI Convertible & Income Fund II, Virtus AllianzGI Diversified Income & Convertible Fund, Virtus AllianzGI Equity & Convertible Income Fund, and Virtus Dividend, Interest & Premium Strategy Fund (hereafter collectively referred to as the "Funds"), as of and for the year ended January 31, 2022, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Funds’ internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinions on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds’ internal control over financial reporting. Accordingly, we do not express an opinion on the effectiveness of the Fund’s internal control over financial reporting. 

The management of the Funds is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company’s assets that could have a material effect on the financial statements. 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. 

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. 

Our consideration of the Funds’ internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Funds’ internal control over financial reporting and their operations, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of January 31, 2022. 

This report is intended solely for the information and use of the Board of Trustees of Virtus AllianzGI Artificial Intelligence & Technology Opportunities Fund, Virtus AllianzGI Convertible & Income 2024 Target Term Fund, Virtus AllianzGI Convertible & Income Fund, Virtus AllianzGI Convertible & Income Fund II, Virtus AllianzGI Diversified Income & Convertible Fund, Virtus AllianzGI Equity & Convertible Income Fund, and Virtus Dividend, Interest & Premium Strategy Fund and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. 


/s/ PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
March 25, 2022



PricewaterhouseCoopers LLP, Two Commerce Square, 2001 Market Street, Suite 1800, Philadelphia, PA 19103-7042
T:(267)330-3000,F:(267)330-3300, www.pwc.com/us